BIOCON
618.55
2019-01-04
BIOCON LTD.
Profitability metrics STANDALONE CONSOLIDATED
Asset Turnover 0.3116 0.4091
Current ratio 2.59 1.67
WC days 215.41 153.97
EBITDA (%) 18.23 23.59
FCF (Rs Cr.) -252 -261
ROCE (%) 4.45 7.91
ROE (%) 3.53 7.18

Solvency metrics STANDALONE CONSOLIDATED
Cash Ratio 0.22 0.5
Div. payout (%) 25.16 16.11
Int. Coverage 306 9.66
LT D/E 0.02 0.44
Solvency Ratio 2.81 0.33

Valuation STANDALONE CONSOLIDATED
Beta 0.5808 0.5808
Div. yield (%) 0 0
EV (Rs Cr.) 35588.1 36593.2
P/BV 5.29 6.88
P/E 149.8 95.84
PEG -1.22 -1.16
P/S 14.7 8.63

Balance sheet metrics STANDALONE CONSOLIDATED
BV/share 112.28 86.32
3Y growth BV/s (%) -13 -47
Cash (Rs Cr.) 196.9 1322.8
Total Debt (Rs Cr.) 133 2264
Net block (Rs Cr.) 902 3699

P&L metrics STANDALONE CONSOLIDATED
DPS 1 1
EPS 3.97 6.2
Net Income (Rs Cr.) 238 372
Operating profit (Rs Cr.) 318 659
No. of o/s shares 60 60
Revenue (Rs Cr.) 2425 4129
Total Income (Rs Cr.) 2549 4356

Cash Flow metrics STANDALONE CONSOLIDATED
CEPS (%) 592 1103
3Y growth CEPS -0.05 0.05
CFF (Rs Cr.) -54 -239
CFI (Rs Cr.) -553 -683
CFO (Rs Cr.) 355 662
FCF (Rs Cr.) -252 -261
3Y growth Op. CF (%) 184 214

Growth metrics STANDALONE CONSOLIDATED
3Y growth dividends (%) -80 -80
1Q growth EBITDA (%) 0 0
3Y growth EBITDA (%) -21 18
4Q growth EBITDA (%) 0 0
1Q growth EPS (%) 0 0
3Y growth EPS (%) -78 -75
4Q growth EPS (%) 0 0
3Y growth Net inc. (%) -34 -25
1Y growth Op. CF (%) 91 3
1Q growth revenue (%) 0 0
3Y growth revenue (%) 8 34
4Q growth revenue (%) 0 0